Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

In Brief Spring 2023

  • Margaret and Michael Bayer

    Margaret and Michael Bayer

    Margaret and Michael Bayer gave $100,000 to establish The Bayer Family Research Fund. The fund aims to accelerate discoveries into safer, more effective and durable treatments for patients facing Waldenström’s macroglobulinemia, a rare form of blood cancer.

    Continue Reading

  • Boston Red Sox Jimmy Fund Award

    Boston Red Sox Jimmy Fund Award

    The 2022 Boston Red Sox Jimmy Fund Award—the Jimmy Fund’s highest honor—was presented to John Berardi (second from right), program director of Jimmy Fund Little League presented by Franklin Sports, which rallies thousands of youth baseball and softball players each summer to fundraise for the Jimmy Fund in their communities and has raised over $6…

    Continue Reading

  • Breast Cancer Alliance

    Breast Cancer Alliance

    Breast Cancer Alliance awarded $125,000 to Dana-Farber to support research into the features of the tumor microenvironment that result in metastatic triple-negative breast cancer (TNBC). This work will improve researchers’ knowledge of the behavior of TNBC and may help identify patients who are more likely to benefit from treatments such as immunotherapy.

    Continue Reading

  • Fred and Michele Brettschneider

    Fred and Michele Brettschneider

    Fred and Michele Brettschneider made a commitment of $250,000 to support a clinical trial network for Waldenström’s macroglobulinemia and advance all clinical research for this rare form of blood cancer within the Bing Center for Waldenström’s Macroglobulinemia.

    Continue Reading

  • Burlingame Foundation

    Burlingame Foundation

    The Burlingame Foundation gave $300,000 to provide support for patient navigation through the Cancer Care Equity Program (CCEP). Patient navigation involves supporting and assisting patients through the complexities of treatment—a key component of the CCEP’s effort to address disparities in cancer care.

    Continue Reading

  • Cross-Check Cancer Women’s Hockey Tournament

    Cross-Check Cancer Women’s Hockey Tournament

    The annual Cross-Check Cancer Women’s Hockey Tournament raised more than $40,000 in 2022, a new record, to support the Adult Survivorship Program in the Perini Family Survivors’ Center at Dana-Farber. The tournament draws 38 teams and more than 470 participants from 11 states to raise funds to ensure a healthy quality of life after cancer.

    Continue Reading

  • Dana-Farber Cancer Institute Presidential Symposium

    Dana-Farber Cancer Institute Presidential Symposium

    In October, Dana-Farber supporters and leaders gathered for the annual Dana-Farber Cancer Institute Presidential Symposium. Attendees received firsthand updates on the State of the Institute, advances and opportunities in prevention and early detection, the impact of philanthropy on advancing research, and Dana-Farber’s world-renowned hematology/oncology fellowship program. Pictured are fellowship program graduates and panelists (from left):…

    Continue Reading

  • David Liposarcoma Research Initiative

    David Liposarcoma Research Initiative

    In September, the inaugural David Liposarcoma Research Initiative International Scientific Symposium was held at Dana-Farber. The symposium included the unveiling of a plaque commemorating the generous pledge from the Rossy Foundation that, through The Rossy Foundation Fund at KBF Canada, established the David Liposarcoma Research Initiative under the direction of George Demetri, MD, director of…

    Continue Reading

  • Emerald Foundation, Inc.

    Emerald Foundation, Inc.

    Emerald Foundation, Inc., awarded $300,000 to support research harnessing natural killer (NK) cells for use in immunotherapies. NK cells play a major role in the elimination of both tumors and infected cells, and this research will provide valuable insight that will inform better treatment strategies.

    Continue Reading

  • A Celebration for the Fellowship Program in Hematology/Oncology Chair at Dana-Farber

    A Celebration for the Fellowship Program in Hematology/Oncology Chair at Dana-Farber

    Spring 2023By Colleen SullivanPhotography by Justin Knight Supporters gathered to celebrate the recently established Fellowship Program in Hematology/Oncology Chair at Dana-Farber. The endowed Chair was funded by colleagues, mentees, grateful patients, family, and friends in honor of Robert J. Mayer, MD, who served as director of the Fellowship Program for more than 35 years. Ann…

    Continue Reading